OrbiMed Capital GP VI LLC
Director, 10% owner at CMPX; Director at IRON; 10% owner at NPCE, and 6 more
- Sold, on record
- $302M
- Dollars the filings state
- Form 4 sales
- 15
- Latest Apr 9, 2025
- Form 144 notices
- 0
- Proposed sales
- Companies
- 9
- Filed as an executive or holder
Companies
- CMPXCompass Therapeutics, Inc.Director, 10% owner
- IRONDisc Medicine, Inc.Director
- NPCENeuroPace Inc10% owner
- VRNAVerona Pharma plcDirector
- SWTXSpringWorks Therapeutics, Inc.10% owner
- ORICOric Pharmaceuticals, Inc.Director
- CELL THERAPEUTICS INC10% owner
- ALPINE IMMUNE SCIENCES, INC.Director, 10% owner
- ETNB89bio, Inc.Director, 10% owner
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- VRNA6.1M shares
- CMPX3.6M shares
- CELL THERAPEUTICS INC2M shares
- SWTX1.4M shares
- ALPINE IMMUNE SCIENCES, INC.600,000 shares
- NPCE510,306 shares
- IRON364,813 shares
- ETNB275,000 shares
- ORIC99,142 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale SWTXPlan not statedSep 12 2022
Sold 153,897 shares at $31.96 ($4.9M)
OrbiMed Capital GP VI LLC, 10% owner
Sold 2.7% of holdings ($184M position)5.6M shares leftFiling
- 2 Form 4 sale VRNAPlan not statedDec 23 +102 days
Sold 6.1M shares at $22.15 ($136M)
OrbiMed Capital GP VI LLC, Director
Sold 15.3% of holdings ($891M position)34.1M shares leftFirst sale on recordFiling
- 3 Form 4 sale NPCENo planOct 3 +284 days
Sold 8,314 shares at $9.07 ($75k)
OrbiMed Capital GP VI LLC, 10% owner
No 10b5-1 planSold 0.2% of holdings ($36.4M position)4M shares leftFirst sale on recordFiling
- 4 Form 4 sale NPCENo planApr 12 +192 days
Sold 485,000 shares at $14.49 ($7M)
OrbiMed Capital GP VI LLC, 10% owner
No 10b5-1 planSold 12.1% of holdings ($58M position)3.5M shares leftFiling
- 5 Form 4 sale NPCENo planApr 18 +6 days
Sold 16,992 shares at $14.02 ($238k)
OrbiMed Capital GP VI LLC, 10% owner
No 10b5-1 planSold 0.5% of holdings ($49.3M position)3.5M shares leftFiling
- 6 Form 4 sale IRONUnusualMar 12 +328 days
Sold 312,384 shares at $54.31 ($17M)
OrbiMed Capital GP VI LLC, Director
No 10b5-1 planSold 61.7% of holdings ($27.5M position)194,209 shares leftFirst sale on recordFiling
- 7 Form 4 sale IRONNo planMar 21 +9 days
Sold 52,429 shares at $54.02 ($2.8M)
OrbiMed Capital GP VI LLC, Director
No 10b5-1 planSold 21.9% of holdings ($12.9M position)187,297 shares leftFiling
- 8 Form 4 sale CMPXUnusualApr 9 +19 days
Sold 3.6M shares at $1.59 ($5.7M)
OrbiMed Capital GP VI LLC, Director, 10% owner
No 10b5-1 planSold 100% of holdings ($5.7M position)0 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (15)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Apr 9, 2025 | CMPX | Director, 10% owner | Form 4 sale | 3.6M | $5.7M | 100.0% | Unusual | SEC |
| Mar 21, 2025 | IRON | Director | Form 4 sale | 52,429 | $2.8M | 21.9% | No plan | SEC |
| Mar 12, 2025 | IRON | Director | Form 4 sale | 312,384 | $17M | 61.7% | Unusual | SEC |
| Apr 18, 2024 | NPCE | 10% owner | Form 4 sale | 16,992 | $238k | 0.5% | No plan | SEC |
| Apr 12, 2024 | NPCE | 10% owner | Form 4 sale | 485,000 | $7M | 12.1% | No plan | SEC |
| Oct 3, 2023 | NPCE | 10% owner | Form 4 sale | 8,314 | $75k | 0.2% | No plan | SEC |
| Dec 23, 2022 | VRNA | Director | Form 4 sale | 6.1M | $136M | 15.3% | Plan not stated | SEC |
| Sep 12, 2022 | SWTX | 10% owner | Form 4 sale | 153,897 | $4.9M | 2.7% | Plan not stated | SEC |
| Jun 28, 2021 | SWTX | 10% owner | Form 4 sale | 6,502 | $554k | 0.1% | Plan not stated | SEC |
| Mar 23, 2021 | ORIC | Director | Form 4 sale | 32,940 | $863k | 1.3% | Plan not stated | SEC |
| Mar 18, 2021 | ORIC | Director | Form 4 sale | 66,202 | $1.9M | 2.6% | Plan not stated | SEC |
| Mar 1, 2021 | SWTX | 10% owner | Form 4 sale | 1.2M | $101M | 16.5% | Plan not stated | SEC |
| Jan 7, 2021 | CELL THERAPEUTICS INC | 10% owner | Form 4 sale | 2M | $7M | 21.0% | Plan not stated | SEC |
| Dec 28, 2020 | ALPINE IMMUNE SCIENCES, INC. | Director, 10% owner | Form 4 sale | 600,000 | $8.6M | 16.3% | Plan not stated | SEC |
| Sep 21, 2020 | ETNB | Director, 10% owner | Form 4 sale | 275,000 | $7.7M | 12.9% | Plan not stated | SEC |